Adial Pharmaceuticals Inc

Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for the treatment or prevention of addiction and related disorders. Its lead product, AD04, is a serotonin-3 antagonist in Phase 3 clinical trials for alcohol use disorder. The company is also developing drug candidates for non-opioid pain reduction and other diseases. Founded in 2010, it is based in Glen Allen, Virginia.